1. In the past 12 months how many patients have been diagnosed with non-tuberculosis mycobacterium (NTM) (A31.0/A31.9)?
1a. Of these how many have been treated with an antibiotic?

2. Do you routinely screen for non-tuberculosis mycobacterium (NTM) (A31.0/A31.9)?
2a. Do you run a NTM (Non-tuberculosis mycobacterium) clinic or service?
Please state any other trusts that share this service?
2b. If you do not have a NTM clinic, where do you refer suspected NTM patients?
2c. How many suspected NTM patients did the trust refer to other institutions in the last 12 months?

3. Which testing laboratory do you send your sputum samples for suspected NTM?
3a. Do have a shared care protocol for treating NTM?

4. Do you run a specific clinic for bronchiectasis patients?
4a. How many patients with bronchiectasis (J47/Q33.4) have you treated in the last 12 months?
4b. How many of these patients have also been diagnosed with non-tuberculosis mycobacterium (NTM) (A31.0/A31.9)
4c. How many of these NTM diagnosed patients are treated long term [more than 12 months] with an antibiotic?
4d. How many of these NTM diagnosed patients are treated long term [more than 12 months] with inhaled or IV amikacin?

5. Do you run a specific clinic for chronic COPD patients?
5a. How many patients with chronic COPD (J44.0, J44.1, J44.8, J44.9) have you treated in the last 12 months?
5b. How many of these patients have also been diagnosed with non-tuberculosis mycobacterium (NTM) (A31.0/A31.9)
5c. How many of these NTM diagnosed patients do you then treat with an antibiotic?
5d. How many of these NTM diagnosed patients do you then treat with inhaled or IV amikacin?

Download response Non-tuberculosis mycobacterium (NTM).130317